| Hugo Guerrero Cazares, M.D., Ph.D., principal investigator |
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma (K01 NS110930) |
NIH |
04/01/19 - 03/31/24 |
| Hugo Guerrero Cazares, M.D., Ph.D., principal investigator |
Role of serpinA3 in the response of glioblastoma to cerebrospinal fluid (R03 NS109444-1) |
NIH |
07/01/18 - 06/30/20 |
| Anna Carrano, Ph.D., principal investigator |
The role of osteopontin-CD44 axis in the interaction between GBM cells and SVZ components |
5th District Eagles Cancer Telethon — Cancer Research Fund Fellowship Program |
06/01/18 - 05/31/20 |
| Alfredo Quinones-Hinojosa, M.D., principal investigator; Hugo Guerrero Cazares, M.D., Ph.D., collaborator |
BMP4 engineered mesenchymal stem cell therapy for glioblastoma (RO1 CA183827) |
NIH |
04/01/15 - 03/31/20 |
| Hugo Guerrero Cazares, M.D., Ph.D., principal investigator |
Role of human cerebrospinal fluid in the invasiveness of human glioblastoma (R21 CA199295-02S1) |
NIH |
09/15/16 - 08/31/18 |
| Hugo Guerrero Cazares, M.D., Ph.D., principal investigator |
Role of human cerebrospinal fluid in the invasiveness of human glioblastoma (R21 CA199295) |
NIH |
07/01/15 - 06/30/17 |
| Jordan J. Green, Ph.D., principal investigator; Hugo Guerrero Cazares, M.D., Ph.D., co-investigator |
Gene delivery of nanoparticles to treat glioblastoma multiforme (R01 EB016721) |
NIH |
04/01/13 - 2/28/17 |
| Hugo Guerrero Cazares, M.D., Ph.D., principal investigator |
Controlling migration of human-derived fetal neural stem cells via slit proteins in a demyelination animal model |
The Maryland Stem Cell Research Fund (MSCRF)-TEDCO |
07/01/13 - 06/30/16 |